Several case reports of orofacial tardive dyskinesia
have found improvements in hyperkinetic movements following BTA injections
in children treated with atypical antipsychotic medications.
The theme of the competition this year concerning tardive dyskinesia
is timely and consistent with the mission of NMSIS to promote knowledge on neurologic side effects of antipsychotic drugs.
[3, 4] In addition, some patients may have gastrointestinal tardive dyskinesia
which causes symptoms, such as discomfort in the stomach, nausea and vomiting.
Other extrapyramidal symptoms that developed in adults were chronic reactions including parkinsonism [3, 4] or tardive dyskinesia
As Tardive dyskinesia
is frequently associated with first generation neuroleptics, these medications should be used restrictively only in major mental disorder and also doses should be kept low.
: a task force report of the American Psychiatric Association.
This report provides comprehensive information on the therapeutic development for Tardive Dyskinesia
, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Topline results for Auspex's Phase III ARM-TD study of SD-809 as a potential treatment for tardive dyskinesia
, a disorder for which there are no approved therapies, are also expected in mid-2015.
Morningside's investment in Synchroneuron demonstrates our belief in the potential of SNC-102 to safely and effectively treat neuropsychiatric disorders such as tardive dyskinesia
as well as its potential in additional indications, said Gerald Chan, Chairman of Morningside Technology Ventures.
Moreover, there is evidence that abnormalities of 5-HT functions are related to the pathophysiology of diverse neurological conditions including Parkinson's disease, tardive dyskinesia
, akathisia, dystonia, Huntington's disease, familial tremor, restless legs syndrome, myoclonus, Gilles de la Tourette's syndrome, multiple sclerosis, sleep disorders, and dementia.
A literature survey reveals that the Pro 197 Leu GSH-Px gene polymorphism has been studied in schizophrenics and patients who developed tardive dyskinesia
due to drugs while it has not been studied in patients with mood disorders.